2024
|
Invention
|
Isolation and use of human lymphoid organ-derived suppressive stromal cells.
A method for suppre... |
|
Invention
|
Reagents for quantitative mass spectrometry.
In some embodiments, a mass spectrometry tag may co... |
|
G/S
|
Active biochemical ingredients being biological molecules
for use in the manufacture of pharmace... |
|
Invention
|
Anti-malarial therapy. Anti-malarial compounds are disclosed for administration to subjects infec... |
|
Invention
|
Developing an anti-human cd45 imaging probe for noninvasive detection of human immune cells. Disc... |
|
Invention
|
Treatment of cancers having a drug-resistant mesenchymal cell state. The subject matter disclosed... |
|
Invention
|
Formulations comprising stabilized sars-cov-2 peptides and uses thereof. Disclosed herein are dry... |
|
Invention
|
Combination therapies comprising stabilized sars-cov-2 peptides. Disclosed herein are methods of ... |
|
Invention
|
Respiratory syncytial virus surface glycoprotein peptides, conjugates, and uses thereof. e.g.e.g.... |
|
Invention
|
Hendra virus and nipah virus surface glycoprotein peptides, conjugates, and uses thereof. e.g.e.g... |
|
Invention
|
Chimeric immunocytokines. Disclosed are mabkines containing a target binding domain, that binds a... |
|
Invention
|
Compositions and methods for targeted immunotherapy.
The present invention provides universal im... |
|
Invention
|
Compositions and methods of preventing t cell exhaustion. The present invention is directed to me... |
|
Invention
|
Drug screening method. in vitroin vitro screening method to identify a SWI/SNF modulating compound. |
|
Invention
|
Compositions and methods for targeted tumor immunotherapy.
The present invention provides univer... |
|
Invention
|
Developing a car-engager platform to enhance the functionality and/or persistence of car t cells.... |
|
Invention
|
Methods for generating dual targeting biotherapeutics that specifically bind proteins present in ... |
|
Invention
|
Mutant-selective egfr inhibitors. The disclosure relates to compounds that act as allosteric inhi... |
|
Invention
|
Novel imidazopyrimidine compound and uses thereof. The present disclosure provides Compound (1), ... |
|
Invention
|
Epitope engineering of cd38 cell-surface receptors. Genetically engineered cells (e.g., HSPCs or ... |
|
Invention
|
Epitope engineering of kit cell-surface receptors. Genetically engineered cells (e.g., HSPCs), su... |
2023
|
Invention
|
Compositions and methods for treating diseases and disorders of the central nervous system.
The ... |
|
Invention
|
Protac degradation of factors pax3 and foxo1. A method of treating rhabdomyosarcoma in a subject ... |
|
Invention
|
Checkpoint modulators for enhancing immunotherapy. Disclosed are binder molecules that can bind t... |
|
Invention
|
Antibodies against edil3 and methods of use thereof. The present invention is directed to human m... |
|
Invention
|
Uses of pyrimidopyrimidinones as sik inhibitors.
The present disclosure provides methods of incr... |
|
Invention
|
Nkg2d-ig fusion protein for cancer immunotherapy.
Methods and compositions for cancer immunother... |
|
Invention
|
Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive nox... |
|
G/S
|
Active biochemical ingredients being biological molecules for use in the manufacture of pharmaceu... |
|
G/S
|
Reagents for scientific or medical research; reagents for diagnostic use, other than medical or v... |
|
Invention
|
Stabilized peptides for covalent binding to target protein.
Provided herein is a platform techno... |
2022
|
Invention
|
Degraders of wild-type and mutant forms of lrrk2 and uses thereof.
Disclosed are bifunctional co... |
|
Invention
|
Compositions and methods for enrichment of nucleic acids using light-mediated cross-linking.
Pro... |
|
Invention
|
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl-acrylamide inhibitors of egfr for use ... |
|
Invention
|
Small molecule disruptors of protein interactions in histone deacetylase complexes.
Disclosed ar... |
|
Invention
|
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers... |
|
Invention
|
Inhibitors of ttbk1.
The present application provides a compound of Formula (I) as described her... |
|
Invention
|
Multi-specific antibody constructs against the muc1-c/extracellular domain (muc1-c/ed).
The pres... |
|
Invention
|
Inhibitors and degraders of pip4k protein.
The present invention relates to compounds, compositi... |
|
Invention
|
Compositions and methods for treating cancer.
This disclosure features human Lymphocyte-activati... |
|
Invention
|
Antibodies against alk and methods of use thereof.
The present invention is directed to human mo... |
|
Invention
|
Class iia histone deacetylase (hdac) degrader ligands and methods of use thereof.
The present in... |
|
Invention
|
Substituted 2-(2,6-dioxopiperidin-3-yl)-5-(1-piperidin-4-yl)isoindoline-1,3-dione derivatives and... |
|
Invention
|
Phthalimido cereblon complex binders and transcription factor degraders and methods of use.
Disc... |
|
Invention
|
Compositions and methods for treating cancer.
This invention comprises compositions and methods ... |
|
Invention
|
Enamine n-oxides: synthesis and application to hypoxia-responsive prodrugs and imaging agents.
D... |
|
Invention
|
Inhibitors of the peptidyl-prolyl cis/trans isomerase (pin1) and uses thereof.
Disclosed are com... |
2021
|
Invention
|
Small molecule degraders of phosphatidylinositol-5-phosphate 4-kinase type 2 and uses thereof.
T... |
|
Invention
|
Methods of cancer detection using extraembryonically methylated cpg islands.
The present inventi... |
|
Invention
|
Compounds for targeted protein degradation of kinases.
The present invention relates to bifuncti... |
2020
|
Invention
|
Immunomodulatory imide drugs as zeta-chain-associated protein kinase 70 (zap70) agonists and uses... |
|
G/S
|
Investment services, namely, capital investment services |
|
G/S
|
medical research services, medical research services in the field of cancer |
|
Invention
|
4h-pyrrolo[3,2-c]pyridin-4-one compounds.
Compounds of formula (I), processes for their producti... |
|
G/S
|
Charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
G/S
|
Charitable fundraising for promotion of public education and
awareness of biomedical sciences re... |
|
G/S
|
charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
G/S
|
Fund-raising services for biomedical sciences research, particularly with regard to the preventio... |
|
G/S
|
Fund-raising services for biomedical sciences research,
particularly with regard to the preventi... |
2019
|
G/S
|
Medical research in the field of prevention, diagnosis and treatment of cancer and AIDS; medical ... |
|
G/S
|
Medical research in the field of prevention, diagnosis and
treatment of cancer and aids; medical... |
|
G/S
|
Medical and scientific research services in the field of diagnosis and treatment of cancer and au... |
|
G/S
|
Medical and scientific research services; providing
information in the fields of medical and sci... |
|
G/S
|
medical and scientific research services; providing information in the fields of medical and scie... |
2018
|
G/S
|
providing multiple user access to a platform for providing risk analysis, prediction, treatment, ... |
2017
|
G/S
|
charitable fundraising services; charitable fundraising services by means of an ice cream festiva... |
|
G/S
|
clinical risk assessment services in the nature of genetic testing for medical purposes based on ... |
2016
|
Invention
|
Methods to treat lymphoplasmacytic lymphoma. The present invention provides compounds of any one ... |
2014
|
G/S
|
Charitable fundraising services; charitable fundraising services by organizing, sponsoring and co... |
2013
|
G/S
|
Charitable fund raising services to raise money for cancer treatment center operations, cancer re... |
2012
|
G/S
|
Providing medical and scientific research information in the fields of clinical trials and cancer... |
|
G/S
|
Charitable fundraising services, namely, fundraising for promotion of public education and awaren... |
2009
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring golf tournaments to raise mon... |
2005
|
G/S
|
Charitable fundraising services, namely raising money for cancer treatment center operations, can... |
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring ice cream eating festivals to... |
|
G/S
|
Charitable fund raising services, namely, sponsoring co-branded license plates that are sold to r... |
2003
|
G/S
|
Reagents for scientific or medical research; Antibodies for use in medical research [ ; Diagnosti... |
2002
|
G/S
|
MEDICAL RESEARCH IN THE FIELD OF PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER AND AIDS MEDICAL S... |
|
G/S
|
Fundraising for promotion of public education and awareness of biomedical sciences research, part... |
2000
|
G/S
|
Charitable and memorial fund raising services for biomedical research, particularly with regard t... |
1998
|
G/S
|
medical research and services in the field of prevention, diagnosis and treatment of cancer and AIDS |
1988
|
G/S
|
FUND-RAISING SERVICES FOR BIOMEDICAL SCIENCES RESEARCH, PARTICULARLY WITH REGARD TO THE PREVENTIO... |